Clinical Outcomes of Genotype-Matched Therapy for Recurrent Gynecological Cancers: A Single Institutional Experience
Recent advances in next-generation sequencing and genome medicine have contributed to treatment decisions in patients with cancer. Most advanced gynecological cancers develop resistance to chemotherapy and have a poor prognosis. Therefore, we conducted genomic tests in gynecological tumors to examin...
Main Authors: | Kiyoka Sawada, Kentaro Nakayama, Kohei Nakamura, Yuki Yoshimura, Sultana Razia, Masako Ishikawa, Hitomi Yamashita, Tomoka Ishibashi, Seiya Sato, Satoru Kyo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/9/10/1395 |
Similar Items
-
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status
by: Kiyoka Sawada, et al.
Published: (2023-04-01) -
Prognostic Value of Peripheral Blood Lymphocyte Telomere Length in Gynecologic Malignant Tumors
by: Kamrunnahar Shanta, et al.
Published: (2020-06-01) -
Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents
by: Yuki Nonomura, et al.
Published: (2022-04-01) -
Comparison of Oncological and Surgical Outcomes of Robot-Assisted, Laparoscopic Modified Radical Hysterectomy and Laparotomy for Endometrial Cancer
by: Masako Ishikawa, et al.
Published: (2024-02-01) -
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study
by: Sultana Razia, et al.
Published: (2023-04-01)